October 08, 2013 07:43 PM Eastern Daylight Time October 08, 2013 07:43 PM Eastern Daylight Time

LA JOLLA, Calif. & MOUNTAIN VIEW, Calif.--( LA JOLLA, Calif. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE BUSINESS WIRE)--NeuroVigil, Inc. is setting to collaborate with a number of partners in )--NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is the Silicon Valley where it is
opening a satellite research laboratory opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other technologies for individuals suffering from ALS and other
conditions conditions affecting the central nervous system. We thank NASA for this wonderful affecting the central nervous system. We thank NASA for this wonderful opportunity and are excited to tap into the resonant energy, sense of opportunity and are excited to tap into the resonant energy, sense of urgency, urgency,
innovation and consumer expertise of Silicon Valley and to innovation and consumer expertise of Silicon Valley and to provide talented individuals with impactful careers which contribute to provide talented individuals with impactful careers which contribute to the public good, said NeuroVigils the public good, said NeuroVigils
Founder, Chairman and CEO, Dr. Founder, Chairman and CEO, Dr. Philip Low. Philip Low.
Based on Dr. Lows PhD research in Computational Neuroscience which Based on Dr. Lows PhD research in Computational Neuroscience which yielded a mathematical framework to convert single-channel sleep and yielded a mathematical framework to convert single-channel sleep and waking waking
encephalography (EEG) into high-resolution maps of brain encephalography (EEG) into high-resolution maps of brain activity, NeuroVigil was able to create a wireless neurotechnology activity, NeuroVigil was able to create a wireless neurotechnology platform including an ultra-light device platform including an ultra-light device
called the iBrain called the iBrain for comfortable at home EEG monitoring, and sophisticated algorithms to for comfortable at home EEG monitoring, and sophisticated algorithms to analyze the data and extract a bank of drug and pathology biomarkers. analyze the data and extract a bank of drug and pathology biomarkers.
Since 2009, the Pharmaceutical Industry and elite academic institutions Since 2009, the Pharmaceutical Industry and elite academic institutions have made use of this neurotechnology platform to better characterize have made use of this neurotechnology platform to better characterize brain activity in response brain activity in response
to compounds or neuropathologies. to compounds or neuropathologies.
In 2011, a kitchen table conversation between Dr. Low, and Dr. Stephen In 2011, a kitchen table conversation between Dr. Low, and Dr. Stephen Hawking inspired Dr. Low to apply his technology for assistive purposes, Hawking inspired Dr. Low to apply his technology for assistive purposes, including to enable including to enable
patients with ALS to interact with their patients with ALS to interact with their environment. Dr. Low and his company have done some outstanding work in environment. Dr. Low and his company have done some outstanding work in this field and I am pleased to be invited to this field and I am pleased to be invited to
collaborate with him and collaborate with him and his colleagues, said Dr. Hawking. Dr. Low unveiled preliminary results his colleagues, said Dr. Hawking. Dr. Low unveiled preliminary results from his collaboration with Dr. Hawking at the Francis Crick Memorial from his collaboration with Dr. Hawking at the Francis Crick Memorial
Conference in Cambridge, UK, in 2012, which Dr. Hawking attended as a Conference in Cambridge, UK, in 2012, which Dr. Hawking attended as a guest of honor during the signing ceremony of the Cambridge Declaration guest of honor during the signing ceremony of the Cambridge Declaration on on
Consciousness, a document formally rejecting the Cartesian assumption Consciousness, a document formally rejecting the Cartesian assumption that Consciousness is a phenomenon restricted to human experience alone. that Consciousness is a phenomenon restricted to human experience alone. Additional Additional
results from the NeuroVigil study may be announced at Dr. results from the NeuroVigil study may be announced at Dr. Lows upcoming keynote address at Israels First Brain Technology Lows upcoming keynote address at Israels First Brain Technology Conference. Conference.
The clinical trial on mind enabled communication for people living with The clinical trial on mind enabled communication for people living with ALS began in Philadelphia in 2012, with the participation of Dr. Terry ALS began in Philadelphia in 2012, with the participation of Dr. Terry Heiman-Patterson, Director Heiman-Patterson, Director
of the MDA/ALS Center of Hope, funded by the of the MDA/ALS Center of Hope, funded by the ALS Hope Foundation. My dream has always been to take the technology ALS Hope Foundation. My dream has always been to take the technology that is available in the here and now and apply that is available in the here and now and apply
that to improve the that to improve the quality of life for people living with ALS and other disabilities. The quality of life for people living with ALS and other disabilities. The potential of the iBrain to allow for more effective communication, to potential of the iBrain to allow for more effective communication, to allow for allow for
interfacing with environmental control and to provide interfacing with environmental control and to provide potential biomarkers to track treatments brings that dream close to a potential biomarkers to track treatments brings that dream close to a reality. The impact will be immeasurable for reality. The impact will be immeasurable for
people living with ALS people living with ALS said Dr. Heiman-Patterson. said Dr. Heiman-Patterson.
NeuroVigil will keep its headquarters in La Jolla and will continue NeuroVigil will keep its headquarters in La Jolla and will continue outreach efforts to veterans and Autism and ALS communities in Southern outreach efforts to veterans and Autism and ALS communities in Southern California, including work California, including work
with Mr. Augie Nieto who was introduced to with Mr. Augie Nieto who was introduced to Dr. Low by Qualcomms Chairman and CEO, Dr. Paul Jacobs. Mr. Nieto is Dr. Low by Qualcomms Chairman and CEO, Dr. Paul Jacobs. Mr. Nieto is the Founder of Life Fitness, the Chief the Founder of Life Fitness, the Chief
Inspirational Officer of Augies Inspirational Officer of Augies Quest, the co-chairman with his wife Lynne of the ALS division of the Quest, the co-chairman with his wife Lynne of the ALS division of the Muscular Dystrophy Association, having raised nearly $40 million for Muscular Dystrophy Association, having raised nearly $40 million for
ALS ALS research and the Chairman of the ALS Therapy Development Institute in research and the Chairman of the ALS Therapy Development Institute in Cambridge, a world leading ALS center with over 50 employees and nearly Cambridge, a world leading ALS center with over 50 employees and nearly 40 scientists 40 scientists
entirely dedicated to ALS research. The collaboration was entirely dedicated to ALS research. The collaboration was recently highlighted in the New York Times and in recently highlighted in the New York Times and in Through Through the Wormhole with Morgan Freeman the Wormhole with Morgan Freeman where Mr. where Mr.
Nieto said: The biggest Nieto said: The biggest fear for someone with ALS is to be not able to communicate! That is fear for someone with ALS is to be not able to communicate! That is called being locked in. With the iBrain, I will never, never be locked called being locked in. With the iBrain, I will never, never be locked in! in!
Upon hearing the news of NeuroVigils NASA satellite lab, Ekso Bionics Upon hearing the news of NeuroVigils NASA satellite lab, Ekso Bionics co-Founder and CEO, Nathan Harding, said: "At Ekso Bionics, we consider co-Founder and CEO, Nathan Harding, said: "At Ekso Bionics, we consider the brain-machine the brain-machine
interface to be the eventual destination of human interface to be the eventual destination of human eksoskeleton interface technology. So, it is very exciting to see one of eksoskeleton interface technology. So, it is very exciting to see one of the major players in the field establishing a the major players in the field establishing a
base in the Bay Area for base in the Bay Area for collaboration." collaboration."
ABOUT NEUROVIGIL ABOUT NEUROVIGIL
NeuroVigil, which was created in 2007, is a world leader in NeuroVigil, which was created in 2007, is a world leader in neurotechnology and computational neuroscience, and is dedicated to the neurotechnology and computational neuroscience, and is dedicated to the betterment of the human betterment of the human
condition by merging non-invasive wireless brain condition by merging non-invasive wireless brain recording technology with advanced computational analysis techniques recording technology with advanced computational analysis techniques applied exclusively on human data. The applied exclusively on human data. The
award-winning company has award-winning company has developed proprietary technology which leverages the dynamic developed proprietary technology which leverages the dynamic oscillations produced across the sleep/wake cycle in order to oscillations produced across the sleep/wake cycle in order to
systematically scan the human brain for signs of pathologic activity systematically scan the human brain for signs of pathologic activity years in advance of cognitive or behavioral symptoms. The company, years in advance of cognitive or behavioral symptoms. The company, headquartered in La Jolla, headquartered in La Jolla,
California, has an active program on California, has an active program on assistive neurotechnologies based at the NASA Research Park, in Mountain assistive neurotechnologies based at the NASA Research Park, in Mountain View, California. For more View, California. For more
information: information: http://www.neurovigil.com http://www.neurovigil.com
Contacts Contacts
NeuroVigil, Inc. NeuroVigil, Inc.
Kathleen Murray, Director of Communications Kathleen Murray, Director of Communications
858-454-5134 858-454-5134
Company Information Company Information
NEUROVIGIL, INC. NEUROVIGIL, INC.
Release Versions Release Versions
Recent Stories Recent Stories
NeuroVigil Launches NASA Satellite Lab to Expand Applications of NeuroVigil Launches NASA Satellite Lab to Expand Applications of Portable Brain Scanner Portable Brain Scanner
TM TM

English English
EON: Enhanced Online News EON: Enhanced Online News
HOME HOME SERVICES SERVICES NEWS NEWS
EDUCATION EDUCATION ABOUT US ABOUT US
Log In Log In Sign Up Sign Up
Search
NeuroVigil Launches NASA Satellite Lab to Expand Applications of Portable Brain Scanner | Business Wire 13.05.2014
http://www.businesswire.com/news/home/20131008006907/en/NeuroVigil-Launches-NASA-Satellite-Lab-Expand-Applications#.U3IFUaIzTMp 1 / 2
Blog Blog Apps Apps Canada Canada UK/Ireland UK/Ireland Deutschland Deutschland France France Hong Kong Hong Kong Italy Italy Japan Japan EON: Enhanced Online News EON: Enhanced Online News Tradeshownews.com Tradeshownews.com
PYMNTS.com PYMNTS.com
More from Business Wire More from Business Wire: :
Contact Us Contact Us Privacy Statement Privacy Statement Terms of Use Terms of Use 2014 Business Wire 2014 Business Wire
NeuroVigil Launches NASA Satellite Lab to Expand Applications of Portable Brain Scanner | Business Wire 13.05.2014
http://www.businesswire.com/news/home/20131008006907/en/NeuroVigil-Launches-NASA-Satellite-Lab-Expand-Applications#.U3IFUaIzTMp 2 / 2